PTGER4 and neoplasm: Intriguingly, scRNA-seq analysis indicates that the expression of EP2 (PTGER2) and EP4 (PTGER4) is negatively correlated with patient prognosis in different tumor types (LUSC, BRCA, LIHC, and OV).